Presenilin-1 mutations increase levels of ryanodine receptors and calcium release in PC12 cells and cortical neurons

被引:270
作者
Chan, SL
Mayne, M
Holden, CP
Geiger, JD
Mattson, MP
机构
[1] NIA, Neurosci Lab, NIH, Baltimore, MD 21224 USA
[2] Univ Kentucky, Sanders Brown Res Ctr Aging, Lexington, KY 40536 USA
[3] Univ Manitoba, Fac Med, Dept Pharmacol & Therapeut, Winnipeg, MB R3E 0W3, Canada
关键词
D O I
10.1074/jbc.M000040200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Many cases of early-onset inherited Alzheimer's disease (AD) are caused by mutations in the presenilin-1 (PSI) gene. PS1 mutations may perturb cellular Ca2+ homeostasis and thereby render neurons vulnerable to excitotoxicity and apoptosis. We now report that PC12 cells expressing PS1 mutations and primary hippocampal neurons from PS1 mutant knockin mice exhibit greatly increased levels of ryanodine receptors (RyR) and enhanced Ca2+ release following stimulation with caffeine. Double-labeling immunostaining and co-immunoprecipitation analyses indicate that PS1 and RyR are colocalized and interact physically, Caffeine treatment sensitizes neurons expressing mutant PS1 to apoptosis induced by amyloid beta-peptide, a neurotic peptide linked to the pathogenesis of AD. When taken together with recent evidence for alterations in RyR in brains of AD patients, our data suggest that PS1 mutations may promote neuronal degeneration in AD by increasing transcription and translation of RyR and altering functional properties of ryanodine-sensitive Ca2+ pools.
引用
收藏
页码:18195 / 18200
页数:6
相关论文
共 38 条
  • [21] Lymphocyte apoptosis: Mediation by increased type 3 inositol 1,4,5-trisphosphate receptor
    Khan, AA
    Soloski, MJ
    Sharp, AH
    Schilling, G
    Sabatini, DM
    Li, SH
    Ross, CA
    Snyder, SH
    [J]. SCIENCE, 1996, 273 (5274) : 503 - 507
  • [22] Elevation of intracellular glucosylceramide levels results in an increase in endoplasmic reticulum density and in functional calcium stores in cultured neurons
    Korkotian, E
    Schwarz, A
    Pelled, D
    Schwarzmann, G
    Segal, M
    Futerman, AH
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (31) : 21673 - 21678
  • [23] Kruman I, 1997, J NEUROSCI, V17, P5089
  • [24] LOCK RB, 1994, CANCER RES, V54, P4933
  • [25] EVIDENCE FOR EXCITOPROTECTIVE AND INTRANEURONAL CALCIUM-REGULATING ROLES FOR SECRETED FORMS OF THE BETA-AMYLOID PRECURSOR PROTEIN
    MATTSON, MP
    CHENG, B
    CULWELL, AR
    ESCH, FS
    LIEBERBURG, I
    RYDEL, RE
    [J]. NEURON, 1993, 10 (02) : 243 - 254
  • [26] MATTSON MP, 1995, METHOD CELL BIOL, V46, P187
  • [27] Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives
    Mattson, MP
    [J]. PHYSIOLOGICAL REVIEWS, 1997, 77 (04) : 1081 - 1132
  • [28] Mattson MP, 1998, J NEUROCHEM, V70, P1
  • [29] Mayne M, 1999, ANN NEUROL, V45, P633, DOI 10.1002/1531-8249(199905)45:5<633::AID-ANA12>3.0.CO
  • [30] 2-X